WY 14,643 inhibits human aldose reductase activity

Sara Klemin, Richard Y. Calvo, S.E. Bond, Heather Dingess, B Rajkumar, Rachel Perez, Lucy Chow, Ganesaratnam K. Balendiran

Journal of Enzyme Inhibition and Medicinal Chemistry · 2006 · 12 citations · 29 references

DOIFull text

Open access

Concepts

Abstract

Aldose reductase (AR) is implicated to play a critical role in diabetes and cardiovascular complications because of the reaction it catalyzes. Our data reveal that peroxisome proliferator WY 14,643, follows a pure non-competitive inhibition pattern in the aldehyde reduction activity as well as in the alcohol oxidation activity of AR. This finding communicates for the first time a novel feature of WY 14,643 in regulating AR activity. In addition, this observation indicates that AR, AR-like proteins and aldo-keto reductase (AKR) members may be involved in the WY 14,643 mechanism of action when it is administered as PPAR agonist.

References

29